Cargando…
Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment
It has been reported that various kinds of immune checkpoint inhibitors (iCIs) could induce immune-related liver damage. We should focus on the programmed cell death-receptor-1 (PD-1) antibody and non-small cell lung cancer (NSCLC) to analyze the characteristics of hepatitis related to iCIs and find...
Autores principales: | Kondo, Yasuteru, Akahira, Junichi, Morosawa, Tatsuki, Toi, Yukihiro, Endo, Akashi, Satio, Hiroaki, Endo, Mareyuki, Sugawara, Shunichi, Tanaka, Yasuhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901662/ https://www.ncbi.nlm.nih.gov/pubmed/35256688 http://dx.doi.org/10.1038/s41598-022-07770-8 |
Ejemplares similares
-
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
por: Kondo, Yasuteru, et al.
Publicado: (2022) -
Preoperative predictors of lymph node metastasis in clinical T1 adenocarcinoma
por: Nakahashi, Kenta, et al.
Publicado: (2020) -
Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring
por: Katsume, Yumi, et al.
Publicado: (2018) -
A Remarkable Clinical Response to Pembrolizumab in a Rare Spindle Cell Carcinoma of the Lung
por: Tsurumi, Kyoji, et al.
Publicado: (2019) -
Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma
por: Kawana, Sachiko, et al.
Publicado: (2020)